论文部分内容阅读
目前用于治疗眼附属器血管瘤的方法很多,但因有严重的并发症而受到限制。本文报告10例眼睑血管瘤用皮质类固醇注射于瘤组织内,作者认为此法优于其他的治疗方法。治疗的适应证包括:阻挡视轴的血管瘤,或迅速增大有可能阻挡视轴的血管瘤,或因血管瘤引起不规则散光而有可能发生弱视者。患儿于全麻下,用27号结核菌素针头进行肿瘤内注射,10例病人中有9例应用去炎舒松(triamcinolone)和倍他米松(betamethasone),1例仅用倍他米松。选择这两种药物的目的是为了使作用迅速的倍他米松和作用时间较长的去炎舒松联合作用。通常是从皮肤的表面直接将药物注入血管瘤内,亦可从睑结膜面注入,对于较大
Currently used for the treatment of adnexal hemangioma many ways, but because of serious complications and limited. This article reports 10 cases of eyelid hemangiomas injected with corticosteroids in the tumor tissue, the authors believe that this method is superior to other treatments. Indications for treatment include: blocking the visual axis of the hemangioma, or the rapid increase may block the visual axis of the hemangioma, or due to hematoma caused by irregular astigmatism and the possible occurrence of amblyopia. Twenty-five tuberculin needles were used for intratumoral injections in children under general anesthesia. Nine of 10 patients were treated with triamcinolone and betamethasone, and one with betamethasone alone. The purpose of choosing these two drugs is to combine the rapid betamethasone with the longer acting triamcinolone. Usually from the skin surface directly into the hemangioma drugs can also be injected from the conjunctiva surface, for larger